Watanabe Nobuo, Kidokoro Masako, Tanaka Makiko, Inoue Shigeaki, Tsuji Tomoatsu, Akatuska Hisako, Okada Chisa, Iida Yumi, Okada Yoshinori, Suzuki Yusuke, Sato Takehito, Yahata Takashi, Hirayama Noriaki, Nakagawa Yoshihide, Inokuchi Sadaki
Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan.
Department of Host Defense Mechanism, Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa 259-1193 Japan.
Cancer Cell Int. 2020 Jun 23;20:263. doi: 10.1186/s12935-020-01328-2. eCollection 2020.
The transmembrane glycoprotein podoplanin (PDPN) is upregulated in some tumors and has gained attention as a malignant tumor biomarker. PDPN molecules have platelet aggregation-stimulating domains and, are therefore, suggested to play a role in tumor-induced platelet activation, which in turn triggers epithelial-to-mesenchymal transition (EMT) and enhances the invasive and metastatic activities of tumor cells. In addition, as forced PDPN expression itself can alter the propensity of certain tumor cells in favor of EMT and enhance their invasive ability, it is also considered to be involved in the cell signaling system. Nevertheless, underlying mechanisms of PDPN in tumor cell invasive ability as well as EMT induction, especially by platelets, are still not fully understood.
Subclonal TE11A cells were isolated from the human esophageal squamous carcinoma cell line TE11 and the effects of anti-PDPN neutralizing antibody as well as PDPN gene knockout on platelet-induced EMT-related gene expression were measured. Also, the effects of PDPN deficiency on cellular invasive ability and motility were assessed.
PDPN-null cells were able to provoke platelet aggregation, suggesting that PDPN contribution to platelet activation in these cells is marginal. Nevertheless, expression of platelet-induced EMT-related genes, including vimentin, was impaired by PDPN-neutralizing antibody as well as PDPN deficiency, while their effects on TGF-β-induced gene expression were marginal. Unexpectedly, PDPN gene ablation, at least in either allele, engendered spontaneous N-cadherin upregulation and claudin-1 downregulation. Despite these seemingly EMT-like alterations, PDPN deficiency impaired cellular motility and invasive ability even after TGF-β-induced EMT induction.
These results suggested that, while PDPN seems to function in favor of maintaining the epithelial state of this cell line, it is indispensable for platelet-mediated induction of particular mesenchymal marker genes as well as the potentiation of motility and invasion capacity.
跨膜糖蛋白血小板内皮细胞黏附分子(PDPN)在某些肿瘤中上调,作为一种恶性肿瘤生物标志物受到关注。PDPN分子具有刺激血小板聚集的结构域,因此被认为在肿瘤诱导的血小板活化中发挥作用,进而触发上皮-间质转化(EMT)并增强肿瘤细胞的侵袭和转移活性。此外,由于强制表达PDPN本身可改变某些肿瘤细胞的倾向,有利于EMT并增强其侵袭能力,因此它也被认为参与细胞信号系统。然而,PDPN在肿瘤细胞侵袭能力以及EMT诱导中的潜在机制,尤其是血小板介导的机制,仍未完全了解。
从人食管鳞状癌细胞系TE11中分离出亚克隆TE11A细胞,检测抗PDPN中和抗体以及PDPN基因敲除对血小板诱导的EMT相关基因表达的影响。此外,评估PDPN缺乏对细胞侵袭能力和运动性的影响。
PDPN缺失的细胞能够引发血小板聚集,表明PDPN对这些细胞中血小板活化的作用很小。然而,血小板诱导的EMT相关基因(包括波形蛋白)的表达受到PDPN中和抗体以及PDPN缺乏的影响,而它们对TGF-β诱导的基因表达的影响很小。出乎意料的是,PDPN基因缺失,至少在任一基因座,导致N-钙黏蛋白自发上调和闭合蛋白-1下调。尽管有这些看似类似EMT的改变,但即使在TGF-β诱导EMT后,PDPN缺乏仍损害细胞运动性和侵袭能力。
这些结果表明,虽然PDPN似乎有利于维持该细胞系的上皮状态,但其对于血小板介导的特定间充质标志物基因的诱导以及运动性和侵袭能力的增强是不可或缺的。